Back to top
more

Illumina (ILMN)

(Real Time Quote from BATS)

$153.70 USD

153.70
1,347,371

+3.94 (2.63%)

Updated Nov 4, 2024 11:56 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 36% (89 out of 250)

Industry: Medical - Biomedical and Genetics

Better trading starts here.

Zacks News

Here's Why You Should Hold on to Illumina (ILMN) Stock for Now

Investors continue to be optimistic about Illumina (ILMN) on its focus on partnerships and robust demand for its products.

GILD vs. ILMN: Which Stock Should Value Investors Buy Now?

GILD vs. ILMN: Which Stock Is the Better Value Option?

Illumina (ILMN) Beats Q1 Earnings Estimates, Withdraws View

Illumina (ILMN) exhibits robust growth in the first quarter of 2020 fueled by strong performance of the sequencing consumable subsegment despite the coronavirus pandemic.

Illumina (ILMN) Q1 Earnings and Revenues Top Estimates

Illumina (ILMN) delivered earnings and revenue surprises of 30.16% and 0.25%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Why Illumina (ILMN) Might Surprise This Earnings Season

Illumina (ILMN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Illumina (ILMN) Expected to Beat Earnings Estimates: Should You Buy?

Illumina (ILMN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Illumina (ILMN) to Report Q1 Earnings: What's in the Offing?

Illumina (ILMN) is upbeat about its first-quarter sequencing consumable revenue growth.

Will Illumina (ILMN) Beat Estimates Again in Its Next Earnings Report?

Illumina (ILMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Earnings Preview: Illumina (ILMN) Q1 Earnings Expected to Decline

Illumina (ILMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Illumina (ILMN) Posts Q1 Preliminary Results, Withdraws View

Investors remain optimistic on Illumina's (ILMN) strong preliminary revenue results for first-quarter 2020.

Sweta Killa headshot

10 Stocks Leading the Rally in the S&P 500 ETF

Signs of a slowdown in the number of hospitalizations and intensive-care admissions in New York and Europe has led to optimism over the reopening of the economy soon and improving activity in the near future.

EXEL vs. ILMN: Which Stock Should Value Investors Buy Now?

EXEL vs. ILMN: Which Stock Is the Better Value Option?

EXEL vs. ILMN: Which Stock Should Value Investors Buy Now?

EXEL vs. ILMN: Which Stock Is the Better Value Option?

Illumina (ILMN) Stock Moves -1.75%: What You Should Know

Illumina (ILMN) closed the most recent trading day at $237.76, moving -1.75% from the previous trading session.

The Zacks Analyst Blog Highlights: Apple, Facebook, AbbVie, Illumina and Freeport-McMoRan

The Zacks Analyst Blog Highlights: Apple, Facebook, AbbVie, Illumina and Freeport-McMoRan

Mark Vickery headshot

Top Research Reports for Apple, Facebook & AbbVie

Today's Research Daily features new research reports on 12 major stocks, including Apple (AAPL), Facebook (FB) and AbbVie (ABBV).

Illumina (ILMN) Stock Moves -1.9%: What You Should Know

Illumina (ILMN) closed the most recent trading day at $273, moving -1.9% from the previous trading session.

Why Is Illumina (ILMN) Down 12.2% Since Last Earnings Report?

Illumina (ILMN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Kevin Cook headshot

Where the Bulls Roam: TSLA, ILMN, SQ, NVTA, TTD

Do you know which investment whales were buying and selling your favorite stocks before the big rally to new highs?

Pacific Biosciences (PACB) Reports Break-Even Earnings in Q4

Pacific Biosciences (PACB) expects softness in first-quarter consumable sales.

Kevin Cook headshot

Coronavirus: How Fast to 100,000 Infected?

The current geometric rate of transmission implies that over 100,000 people could be infected by early February.

Illumina (ILMN) Q4 Earnings Beat Estimates, Margins Expand

Illumina (ILMN) exhibits robust growth in the fourth quarter of fiscal 2019, fueled by strong performance of the sequencing consumable segment.

Illumina (ILMN) Q4 Earnings and Revenues Top Estimates

Illumina (ILMN) delivered earnings and revenue surprises of 6.92% and 0.63%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Kevin Cook headshot

Coronavirus: Epidemic or Pandemic?

The current geometric rate of transmission implies that over 100,000 people could be infected by early February.

Can Sequencing Products Aid Illumina (ILMN) in Q4 Earnings?

Illumina (ILMN) is upbeat about fourth-quarter and fiscal 2019 results after a strong third-quarter performance.